Results 241 to 250 of about 2,418,826 (273)

Estimating the ovarian cancer CA-125 preclinical detectable phase, in-vivo tumour doubling time, and window for detection in early stage: an exploratory analysis of UKCTOCS. [PDF]

EBioMedicine
Bedia JS, Jacobs IJ, Ryan A, Gentry-Maharaj A, Burnell M, Singh N, Manchanda R, Kalsi JK, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Parmar MKB, Menon U, Skates SJ.   +14 more
europepmc   +1 more source

The Potential Role of CA-125 as a Biomarker for Short-Term Mortality Risk in Patients with Acute Symptomatic Pulmonary Embolism. [PDF]

J Clin Med
Oblitas CM, Galeano-Valle F, Lago-Rodríguez MO, López-Rubio M, Baltasar-Corral J, García-Gámiz M, Zamora-Trillo A, Alvarez-Sala Walther LA, Demelo-Rodríguez P.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

CA 125 and TB

BMJ Case Reports, 2021
We present two unusual presentations of extrapulmonary tuberculosis (EPTB) and more specifically intra-abdominal tuberculosis (TB). These cases were initially suspicious for ovarian cancer, presenting with non-specific symptoms, ultrasound-confirmed ascites and elevated cancer antigen 125 tumour marker (CA 125).
Mirae Park, Ranju Dhawan, Elizabeth Whittaker, Onn Min Kon   +3 more
openaire   +2 more sources

?????????????????????? ???????????????????????????????????? ???????????? CA 125 ?? ?????????????????? ?????????? ?????????????? ?????????? ?????????????? ?????????? ???????????????????????????????? ??????????????

2012
?????? ?????????????????????????? ???? 125 ?????? ???????????????????????????????? ?????????????? ?????????????? ?????????????? ?????????? ?????????????? (????) ???????????? ???????????????? ???????????????? ???????????????????????????????????? ???????????? ?????????? ?????????????? ?? ?????????????????? ?????????? ?????????????? ?????????? ????????????
J. A. M. van Balen, A. A. Demeulemeester, M. Frölich, K. Mohrmann, L. M. Harms, W. C. H. van Helden, L. J. Mostert, J.H.M. Souverijn   +7 more
openaire   +3 more sources

CA 125 in gynecologic practice

American Journal of Obstetrics and Gynecology, 1986
Serum CA 125 levels were determined in 64 women with benign ovarian lesions, 92 women with uterine fundal lesions, and six patients who had negative second-look laparotomy for epithelial ovarian carcinoma. Of those with benign lesions, 13 of 31 patients with endometriosis had levels greater than 35 U/ml.
G D, Malkasian, K C, Podratz, C R, Stanhope, R E, Ritts, V R, Zurawski   +4 more
openaire   +2 more sources

CA-125 levels in endometriosis

Fertility and Sterility, 1986
CA-125 is a cellular antigen detected in many patients with ovarian cancer, but it has also been detected in patients with endometriosis. Preoperative CA-125 levels were drawn from 113 patients before they underwent laparoscopy. Patients were categorized into diagnostic groups on the basis of pathologic findings. CA-125 levels in patients with evidence
P E, Patton, C S, Field, R W, Harms, C B, Coulam   +3 more
openaire   +2 more sources

CA-125 in gynecological malignancies

European Journal of Cancer and Clinical Oncology, 1987
CA-125 is an antigenic determinant that can be demonstrated in the majority of epithelial ovarian carcinomas. It can be measured in the serum with a radioimmunoassay by means of a monoclonal antibody. The tumor marker has a low specificity but high sensitivity for ovarian cancer, especially for serous cystadenocarcinoma.
W, Meier, P, Stieber, A, Fateh-Moghadam, W, Eiermann, H, Hepp   +4 more
openaire   +2 more sources

CA-125 and heart failure

International Journal of Cardiology, 2011
…
Ege, Meltem Refiker, Zorlu, Ali, Yilmaz, Mehmet Birhan   +2 more
openaire   +4 more sources

CA 125 in the management of endometriosis

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1993
CA 125 is expressed by eutopic and ectopic endometrium. In women with advanced endometriosis, plasma concentrations are increased towards the end of the luteal phase and during menstruation but not during the follicular and early luteal phases. In women without endometriosis, such cyclic changes of CA 125 in plasma are not observed.
P R, Koninckx, M, Muyldermans, C, Meuleman, F J, Cornillie   +3 more
openaire   +2 more sources

CA-125 in Women with Endometriosis

Obstetrics and Gynecology Clinics of North America, 1989
The serum CA-125 level is elevated in most women with endometriosis. Although tests are readily available to measure the marker, simple modifications of the present assays are required to improve and standardize the quality of the measurements. The serum test has low sensitivity and would not be appropriate for general screening purposes, but in ...
openaire   +2 more sources